Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
28.27
+0.61 (2.21%)
Mar 6, 2026, 4:00 PM EST - Market closed
Assembly Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 37.19 | 28.52 | 7.16 | - | 6.25 | 79.11 | Upgrade
|
| Revenue Growth (YoY) | 31.30% | 298.16% | - | - | -92.09% | 395.55% | Upgrade
|
| Cost of Revenue | 61.84 | 55.93 | 48.9 | 69.08 | 70.15 | 101.34 | Upgrade
|
| Gross Profit | -24.65 | -27.41 | -41.74 | -69.08 | -63.9 | -22.23 | Upgrade
|
| Selling, General & Admin | 18.8 | 18.01 | 22.91 | 23.93 | 28.5 | 36.86 | Upgrade
|
| Operating Expenses | 18.8 | 18.01 | 22.91 | 23.93 | 28.5 | 36.86 | Upgrade
|
| Operating Income | -43.45 | -45.42 | -64.65 | -93.01 | -92.4 | -59.09 | Upgrade
|
| Interest & Investment Income | 4.83 | 5.57 | 3.45 | 1.02 | 0.3 | 2.62 | Upgrade
|
| EBT Excluding Unusual Items | -38.62 | -39.85 | -61.2 | -91.99 | -92.1 | -56.47 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -1.1 | 1.35 | -5.68 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -12.6 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.04 | - | Upgrade
|
| Pretax Income | -38.62 | -39.85 | -61.2 | -93.09 | -132.39 | -62.15 | Upgrade
|
| Income Tax Expense | -0.08 | 0.33 | 0.03 | - | -2.53 | - | Upgrade
|
| Net Income | -38.55 | -40.18 | -61.23 | -93.09 | -129.86 | -62.15 | Upgrade
|
| Net Income to Common | -38.55 | -40.18 | -61.23 | -93.09 | -129.86 | -62.15 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 6 | 5 | 4 | 4 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 6 | 5 | 4 | 4 | 3 | Upgrade
|
| Shares Change (YoY) | 51.02% | 31.18% | 13.47% | 11.85% | 22.17% | 34.91% | Upgrade
|
| EPS (Basic) | -4.48 | -6.69 | -13.38 | -23.08 | -36.00 | -21.05 | Upgrade
|
| EPS (Diluted) | -4.48 | -6.69 | -13.38 | -23.08 | -36.00 | -21.05 | Upgrade
|
| Free Cash Flow | -55.78 | -51.15 | 22.49 | -84.57 | -96.49 | -63.43 | Upgrade
|
| Free Cash Flow Per Share | -6.48 | -8.52 | 4.91 | -20.96 | -26.75 | -21.48 | Upgrade
|
| Gross Margin | -66.29% | -96.12% | - | - | - | -28.10% | Upgrade
|
| Operating Margin | -116.83% | -159.26% | -902.50% | - | -1477.42% | -74.70% | Upgrade
|
| Profit Margin | -103.65% | -140.87% | -854.78% | - | -2076.35% | -78.57% | Upgrade
|
| Free Cash Flow Margin | -149.98% | -179.33% | 313.95% | - | -1542.88% | -80.18% | Upgrade
|
| EBITDA | -43.32 | -45.29 | -64.2 | -92.52 | -91.93 | -58.4 | Upgrade
|
| EBITDA Margin | -116.48% | -158.80% | - | - | - | -73.83% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.13 | 0.45 | 0.5 | 0.47 | 0.69 | Upgrade
|
| EBIT | -43.45 | -45.42 | -64.65 | -93.01 | -92.4 | -59.09 | Upgrade
|
| EBIT Margin | -116.83% | -159.26% | - | - | - | -74.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.